Working... Menu
Trial record 14 of 14 for:    "Sickle Beta Thalassemia"

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02061800
Recruitment Status : Recruiting
First Posted : February 13, 2014
Last Update Posted : March 13, 2019
Information provided by (Responsible Party):
Diane George, MD, Columbia University

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 2019
  Estimated Study Completion Date : December 2019